Actavis PLC $219.56

up +3.19


23/7/2014 03:05 PM  |  NYSE : ACT  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get ACT Trend Analysis - it has outperformed the S&P 500 by 52%

Partner Headlines

  1. Medicines360 And Actavis Announce FDA Acceptance For Filing Of NDA For ...

    Benzinga
  2. Enable Partners, Other Leaders Facing Market Pressure

    IBD
  3. Actavis Looks To Keep Up Momentum In Spite Of Yellen's Report

    Benzinga
  4. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  5. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  6. Actavis Fuels Growth With Acquisitions, New Generics

    IBD
  7. ACTAVIS

    IBD
  8. Stocks Ease Off Lows; King Digital Turns Tail

    IBD
  9. What Stocks Top Funds Are Buying Now

    IBD
  10. ACTAVIS

    IBD
  11. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  12. Many IBD 50 Stocks Struggle To Climb After Breakouts

    IBD
  13. Novo, Other Medicals Display Healthy Action

    IBD
  14. Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 5 ...

    Benzinga
  15. Diamond Hill Capital Comments on Actavis Inc

    GuruFocus
  16. Diamond Hill Small Cap Fund Commentary - First Quarter 2014

    GuruFocus
  17. Actavis and Forest Announce Tentative Election Deadline of June 27, 2014

    Benzinga
  18. Bulls Take A Break As Dow's Winning Streak Ends At 7 Days

    Benzinga
  19. Major Indexes Narrowly Lower As Actavis Rallies

    IBD
  20. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  21. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  22. Market Wrap For June 18: Markets Rally On Fed Comments And Tapering

    Benzinga
  23. Nasdaq, S&P 500 Rally To New Highs After Fed Meeting

    IBD
  24. Stocks Open Mixed In Firm Trade; Adobe, FedEx, Air Products Jump

    IBD
  25. UPDATE: Morgan Stanley Resumes Coverage On Actavis Following Forest Acquisition

    Benzinga
  26. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  27. Actavis Strives To Reduce Borrowing Costs

    IBD
  28. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  29. Actavis, BitAuto Among Leading World Stocks In Bases

    IBD
  30. Lannett In Buying Range After Breakout From Cup Base

    IBD
  31. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  32. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
  33. More Stock Leaders Emerge From More Industry Groups

    IBD
  34. Chicago sues painkiller firms

    IBD
  35. Top New Buys: Funds Pile Into Actavis, chip stocks

    IBD
  36. Oakmark Funds' Bill Nygren Buys 4 New Stocks

    GuruFocus
  37. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  38. Market Wrap For May 12: Dow And S&P Close At Record Highs

    Benzinga
  39. Actavis, Michael Kors Among World Stocks Near Buy Points

    IBD
  40. Top Acquisitions Of Big Tech Companies

    Benzinga
  41. AstraZeneca Nixes New Bid As Pfizer Woos British PM

    IBD
  42. A Look At World Stocks' Q1: Shire, Actavis, NXP Semi

    IBD
  43. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  44. Actavis Earns Over-The-Top Q1

    IBD
  45. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  46. Market Wrap For April 30: Markets Positive Despite Fed Tapering and GDP ...

    Benzinga
  47. Stocks Narrowly Mixed As Fed Announcement Looms

    IBD
  48. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  49. Forest Laboratories

    IBD
  50. Stocks Rise In Weak Trade; Twitter Dives After-Hours

    IBD
Trading Center